A Study of Duloxetine Hydrochloride Hard Gelatinous Capsule Compared To Cymbalta

PHASE4WithdrawnINTERVENTIONAL
0
Timeline

Start Date

March 30, 2020

Primary Completion Date

June 7, 2020

Study Completion Date

June 7, 2020

Conditions
Healthy
Interventions
DRUG

Cymbalta Capsules

Active Comparator: Cymbalta®- hard gelatinous capsule with delayed release microgranules ( Eli Lilly do Brasil Ltda) equivalent to 60 mg of duloxetine.

DRUG

Duloxetine Hydrochloride Capsules

Experimental Drug: Duloxetine hydrochloride - hard gelatinous capsule with delayed release microgranules (Pfizer S.R.L - Argentina.) equivalent to 60 mg of duloxetine.

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Pfizer

INDUSTRY

NCT03729284 - A Study of Duloxetine Hydrochloride Hard Gelatinous Capsule Compared To Cymbalta | Biotech Hunter | Biotech Hunter